Growth Metrics

Fennec Pharmaceuticals (FENC) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -82.39%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -97.49%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -79.34%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 61.45%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,178.57%
10 Fennec Pharmaceuticals 281.48 Mn 244.70 Mn 7.67 Mn -100.00%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -100.00%
Sep 30, 2025 90.48%
Jun 30, 2025 45.00%
Mar 31, 2025 -109.76%
Dec 31, 2024 20.00%
Sep 30, 2024 -200.00%
Jun 30, 2024 4.76%
Mar 31, 2024 278.26%
Dec 31, 2023 60.00%
Sep 30, 2023 77.42%
Jun 30, 2023 -10.53%
Mar 31, 2023 -64.29%
Dec 31, 2022 -47.06%
Sep 30, 2022 -93.75%
Jun 30, 2022 -26.67%
Mar 31, 2022 22.22%
Dec 31, 2021 -41.67%
Sep 30, 2021 33.33%
Jun 30, 2021 28.57%
Mar 31, 2021 5.26%
Sep 30, 2020 -166.67%
Jun 30, 2020 12.50%
Mar 31, 2020 -235.71%
Sep 30, 2019 35.71%
Jun 30, 2019 -71.43%
Mar 31, 2019 255.56%
Sep 30, 2018 6.67%
Jun 30, 2018 -27.27%
Mar 31, 2018 -50.00%
Sep 30, 2017 -275.00%
Jun 30, 2017 -83.33%
Mar 31, 2017 -50.00%
Sep 30, 2016 -300.00%
Jun 30, 2016 -200.00%
Mar 31, 2016 -500.00%
Sep 30, 2015 -133.33%
Jun 30, 2015 75.00%
Mar 31, 2015 103.03%
Dec 31, 2014 454.90%
Sep 30, 2014 602.88%
Jun 30, 2014 -120.55%
Mar 31, 2014 -1,451.80%
Dec 31, 2013 10.67%
Sep 30, 2013 75.99%
Jun 30, 2013 99.93%
Mar 31, 2013 -119.33%
Dec 31, 2012 99.88%
Sep 30, 2012 35.96%
Jun 30, 2012 -217,526.53%
Mar 31, 2012 -42.11%
Dec 31, 2011 -73,356.28%
Sep 30, 2011 12.20%
Jun 30, 2011 -16.96%